Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-13 Sale |
2023-01-13 6:33 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Interim President & CEO |
6,766 | $15 | $101,490 | 499,864 (Direct) |
View |
| 2022-06-07 Sale |
2022-06-08 7:33 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
71,435 | $8.0898 | $577,895 | 593,153 (Direct) |
View |
| 2022-06-02 Sale |
2022-06-06 7:00 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
66,622 | $7.9975 | $532,810 | 1,054,819 (Direct) |
View |
| 2022-04-07 Sale |
2022-04-11 5:00 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
5,631 | $24.02 | $135,228 | 731,210 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 7:00 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
94,251 | $24.16 | $2,276,684 | 1,309,602 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 4:30 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
10,000 | $12.16 | $121,578 | 506,630 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 4:30 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
8,215 | $14.27 | $117,197 | 516,630 (Direct) |
View |
| 2021-01-20 Sale |
2021-01-22 4:30 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
10,000 | $12.08 | $120,826 | 524,845 (Direct) |
View |
| 2020-07-08 Sale |
2020-07-09 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
2,500 | $20 | $50,000 | 534,845 (Direct) |
View |
| 2020-06-25 Sale |
2020-06-26 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
2,500 | $20.8 | $51,992 | 537,345 (Direct) |
View |
| 2020-06-09 Sale |
2020-06-10 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
156 | $20 | $3,120 | 539,845 (Direct) |
View |
| 2020-06-05 Sale |
2020-06-09 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
3,433 | $20.17 | $69,251 | 540,001 (Direct) |
View |
| 2020-06-03 Sale |
2020-06-05 4:26 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
2,800 | $20.09 | $56,250 | 543,434 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-03 4:17 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
2,802 | $20 | $56,040 | 546,234 (Direct) |
View |
| 2020-05-28 Sale |
2020-06-01 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
3,309 | $20.04 | $66,302 | 549,036 (Direct) |
View |
| 2020-05-26 Sale |
2020-05-28 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
2,500 | $20 | $50,000 | 552,345 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-03 Option Award |
2024-07-02 4:45 pm |
N/A 2034-06-02 |
Turnstone Biologics Corp. | TSBX | Gould Robert J Director |
12,770 | $0 | 12,770 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2023-07-20 9:50 pm |
N/A 2029-06-09 |
Turnstone Biologics Corp. | TSBX | Gould Robert J Director |
0 | $0 | 52,902 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:16 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Interim President & CEO |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-07 Exercise |
2022-06-08 7:33 pm |
N/A 2022-06-30 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
71,435 | $0 | 593,153 (Direct) |
View |
| 2022-06-07 Exercise |
2022-06-08 7:33 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
71,435 | $7.84 | 593,153 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-06 7:00 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
66,622 | $0 | 1,054,819 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-06 7:00 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
66,622 | $7.84 | 1,054,819 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 5:00 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
5,631 | $0 | 731,210 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 5:00 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
5,631 | $7.84 | 731,210 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 7:00 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
94,251 | $0 | 1,309,602 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 7:00 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
94,251 | $7.84 | 1,309,602 (Direct) |
View |
| 2021-02-02 Option Award |
2021-02-04 4:35 pm |
N/A 2031-02-01 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
269,390 | $0 | 269,390 (Direct) |
View |